EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Discovery and Biosynthesis of Persiathiacins: Unusual Polyglycosylated Thiopeptides Active Against Multidrug Resistant Tuberculosis

Yousef Dashti iD, Fatemeh Mohammadipanah iD, Yu Zhang, Pietra M Cerqueira Diaz, Anthony Vocat, Daniel Zabala, Christopher D Fage iD, Isolda Romero-Canelon iD, Boyke Bunk, Cathrin Spröer, Lona M Alkhalaf iD, Jörg Overmann und 2 weitere

ACS Infectious Diseases · 2024

DOI: 10.1021/acsinfecdis.4c00502 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Infectious Diseases, 2024. Verfasst von Yousef Dashti und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, University of Warwick, Coventry CV4 7AL, U.K. Hauptthemen laut MEDLINE: Mycobacterium tuberculosis, Tuberculosis, Multidrug-Resistant, Multigene Family. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 59 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Medical Research Council, Royal Society, Research Councils UK.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Mycobacterium tuberculosisTuberculosis, Multidrug-ResistantMultigene FamilyHumansMicrobial Sensitivity TestsAntitubercular AgentsMethicillin-Resistant Staphylococcus aureusGlycosylationActinobacteriaBiosynthetic PathwaysPeptides

Stichwörter der Autor:innen

6-deoxysugarRiPPantibioticcytochrome P450glycosyl transferase

Substanzen

Antitubercular AgentsPeptides

Autor:innen und Institutionen

  • Department of Chemistry, University of Warwick, Coventry CV4 7AL, U.K.
  • Sydney Infectious Diseases Institute, Faculty of Medicine and Health, University of Sydney, Sydney NSW 2015, Australia.
  • Pharmaceutical Biotechnology Lab, School of Biology and Center of Excellence in Phylogeny of Living Organisms, College of Science, University of Tehran, 14155-6455 Tehran, Iran.
  • Global Health Institute, Ecole Polytechnique Fédérale de Lausanne, Station 19, 1015 Lausanne, Switzerland.
  • School of Pharmacy, Institute of Clinical Sciences, University of Birmingham, Birmingham B15 2TT, U.K.
  • Leibniz-Institute DSMZ-German Collection of Microorganisms and Cell Cultures, 38124 Braunschweig, Germany.

ORCID-Profile: Yousef Dashti, Fatemeh Mohammadipanah, Christopher D Fage, Isolda Romero-Canelon, Lona M Alkhalaf, Gregory L Challis

Förderung

  • Medical Research Council
  • Royal Society
  • Research Councils UK
  • Biotechnology and Biological Sciences Research Council

Zitieren

APA

Dashti, Y., Mohammadipanah, F., Zhang, Y., Cerqueira Diaz, P. M., Vocat, A., Zabala, D., Fage, C. D., Romero-Canelon, I., Bunk, B., Spröer, C., Alkhalaf, L. M., Overmann, J., Cole, S. T., & Challis, G. L. (2024). Discovery and Biosynthesis of Persiathiacins: Unusual Polyglycosylated Thiopeptides Active Against Multidrug Resistant Tuberculosis. ACS Infectious Diseases. https://doi.org/10.1021/acsinfecdis.4c00502

Vancouver

Dashti Y, Mohammadipanah F, Zhang Y, Cerqueira Diaz PM, Vocat A, Zabala D, et al. Discovery and Biosynthesis of Persiathiacins: Unusual Polyglycosylated Thiopeptides Active Against Multidrug Resistant Tuberculosis. ACS Infectious Diseases. 2024. doi:10.1021/acsinfecdis.4c00502

BibTeX
@article{Dashti2024,
  author = {Dashti, Yousef and Mohammadipanah, Fatemeh and Zhang, Yu and Cerqueira Diaz, Pietra M and Vocat, Anthony and Zabala, Daniel and Fage, Christopher D and Romero-Canelon, Isolda and Bunk, Boyke and Spröer, Cathrin and Alkhalaf, Lona M and Overmann, Jörg and Cole, Stewart T and Challis, Gregory L},
  title = {Discovery and Biosynthesis of Persiathiacins: Unusual Polyglycosylated Thiopeptides Active Against Multidrug Resistant Tuberculosis},
  journal = {ACS Infectious Diseases},
  year = {2024},
  doi = {10.1021/acsinfecdis.4c00502}
}
Kostenlos starten →